These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21429977)

  • 1. Attention-deficit hyperactivity disorder, drug companies and the internet.
    Mitchell J; Read J
    Clin Child Psychol Psychiatry; 2012 Jan; 17(1):121-39. PubMed ID: 21429977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia, drug companies and the internet.
    Read J
    Soc Sci Med; 2008 Jan; 66(1):99-109. PubMed ID: 17826878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A literature review and meta-analysis of drug company-funded mental health websites.
    Read J; Cain A
    Acta Psychiatr Scand; 2013 Dec; 128(6):422-33. PubMed ID: 23662697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttraumatic stress disorder, drug companies, and the Internet.
    Mansell P; Read J
    J Trauma Dissociation; 2009; 10(1):9-23. PubMed ID: 19197709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction and the internet: drug company manipulation of public and professional opinion.
    Read J; Mati E
    J Sex Marital Ther; 2013; 39(6):541-59. PubMed ID: 23672238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation and evaluation of UK websites on attention deficit hyperactivity disorder.
    Akram G; Thomson AH; Boyter AC; Morton MJ
    Arch Dis Child; 2008 Aug; 93(8):695-700. PubMed ID: 18337283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Internet information referring to mental health and mental disorders in Japan.
    Nemoto K; Tachikawa H; Sodeyama N; Endo G; Hashimoto K; Mizukami K; Asada T
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):243-8. PubMed ID: 17472591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internet information on colorectal cancer: commercialization and lack of quality control.
    Sajid MS; Iftikhar M; Monteiro RS; Miles AF; Woods WG; Baig MK
    Colorectal Dis; 2008 May; 10(4):352-6. PubMed ID: 17645570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSM-5 further inflates attention deficit hyperactivity disorder.
    Batstra L; Frances A
    J Nerv Ment Dis; 2012 Jun; 200(6):486-8. PubMed ID: 22652611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical company internet sites as sources of information about antidepressant medications.
    Graber MA; Weckmann M
    CNS Drugs; 2002; 16(6):419-23. PubMed ID: 12027787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer perceptions of prescription drug websites: a pilot study.
    Wymer W
    Health Mark Q; 2010 Apr; 27(2):173-94. PubMed ID: 20446140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Communication and transparency concerning risk-benefit analysis in public health: the example of medication].
    Lehner JP; Meyer F; Juillet Y
    Therapie; 2001; 56(4):335-9. PubMed ID: 11677849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of 'patient-oriented evidence that matters' on the Internet: the case of Type 2 diabetes treatment.
    Giménez-Pérez G; Caixàs A; Giménez-Palop O; González-Clemente JM; Mauricio D
    Diabet Med; 2005 Jun; 22(6):688-92. PubMed ID: 15910617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persuasion and types of enticements offered by pharmaceutical companies to Gold Coast general practitioners in an attempt to encourage a health website recommendation.
    Usher W; Skinner J
    Health Soc Care Community; 2010 Jan; 18(1):100-5. PubMed ID: 19674124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.